AkaRx's Acquisition

AkaRx was acquired by Eisai Corporation on January 06, 2010.

AkaRx develops therapeutic products including avatrombopag, which is an investigational oral thrombopoietin receptor agonist.…

Articles about AkaRx's Acquisition: